Clinical benefits of prolonged dual antiplatelet therapy following complex percutaneous coronary intervention

Area of Science:

• Cardiology
• Interventional Cardiology

Background:

• Dual antiplatelet therapy (DAPT) duration is critical, balancing thrombotic event reduction against bleeding risk.
• Complex percutaneous coronary intervention (PCI) presents unique challenges in managing DAPT.
• Optimizing DAPT duration in complex PCI requires careful consideration of patient-specific factors and procedural complexity.

Purpose of the Study:

• To evaluate the safety and efficacy of prolonged DAPT (>12 months) in patients who have undergone complex PCI.
• To analyze the trade-off between reduced thrombotic events and increased bleeding risk with extended DAPT in this population.

Main Methods:

• A comprehensive literature search was conducted across major databases.
• Complex PCI was defined by specific angiographic criteria (e.g., multi-vessel, multi-lesion, long stent length, specific anatomical locations).
• A meta-analysis using a random-effects model was performed on 5 eligible studies comparing short versus prolonged DAPT.

Main Results:

• Prolonged DAPT was associated with a significant reduction in cardiac mortality (OR 0.57) and major adverse cardiovascular events (OR 0.76).
• A significant increase in major bleeding events was observed with prolonged DAPT (OR 1.75).
• No significant difference in all-cause mortality was found between short and prolonged DAPT durations.

Conclusions:

• Prolonged DAPT demonstrates a favorable efficacy profile in complex PCI, reducing cardiac mortality and MACE.
• The increased bleeding risk associated with prolonged DAPT necessitates careful risk-benefit assessment.
• Further validation in larger randomized controlled trials is warranted to confirm these findings.